Clinical Research Detail Title Of Study A Multi Centre, Pilot Phase II Trial Assessing The Efficacy And Safety Of Bevacizumab + Gemcitabine + Carboplatin As First Line Treatment For Patients Diagnosed With Triple Negative Metastatic Breast Cancer. Disease Condition Metastatic breast cancer Estrogen receptor- , progesterone- and HER2-negative disease Phase of Trial Phase-2 Discipline Oncology Start date of Trial 2/15/2011 Closing Date of Trial 2/15/2014 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]